Long-term soy isoflavone supplementation and cognition in women
A randomized, controlled trial
Make Comment
See Comments
Share
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objective: To determine the cognitive effects of long-term dietary soy isoflavones in a daily dose comparable to that of traditional Asian diets.
Methods: In the double-blind Women's Isoflavone Soy Health trial, healthy postmenopausal women were randomly allocated to receive daily 25 g of isoflavone-rich soy protein (91 mg of aglycone weight of isoflavones: 52 mg of genistein, 36 mg of daidzein, and 3 mg glycitein) or milk protein−matched placebo. The primary cognitive endpoint compared between groups at 2.5 years was change from baseline on global cognition, a composite of the weighted sum of 14 neuropsychological test score changes. Secondary outcomes compared changes in cognitive factors and individual tests.
Results: A total of 350 healthy postmenopausal women aged 45–92 years enrolled in this trial; 313 women with baseline and endpoint cognitive test data were included in intention-to-treat analyses. Adherence in both groups was nearly 90%. There was no significant between-group difference on change from baseline in global cognition (mean standardized improvement of 0.42 in the isoflavone group and 0.31 in the placebo group; mean standardized difference 0.11, 95% confidence interval [CI] −0.13 to 0.35). Secondary analyses indicated greater improvement on a visual memory factor in the isoflavone group (mean standardized difference 0.33, 95% CI 0.06–0.60) but no significant between-group differences on 3 other cognitive factors or individual test scores, and no significant difference within a subgroup of younger postmenopausal women.
Conclusion: For healthy postmenopausal women, long-term dietary soy isoflavone supplementation in a dose comparable to that of traditional Asian diets has no effect on global cognition but may improve visual memory.
Classification of evidence: This study provides Class I evidence that long-term dietary supplementation with isoflavone-rich soy protein does not improve global cognition of healthy postmenopausal women.
GLOSSARY
- CI=
- confidence interval;
- ISP=
- isoflavone-rich soy protein;
- WISH=
- Women's Isoflavone Soy Health
Footnotes
Study funding: Supported by the National Center of Complementary and Alternative Medicine, the Office of Dietary Supplements, and the Office of Research on Women's Health (NIH grant U01-AT001653). Solae LLC (St. Louis, MO) provided study products without charge.
WISH Research Group Coinvestigators are listed on the Neurology® Web site at www.neurology.org.
Supplemental data at www.neurology.org
- Received November 8, 2011.
- Accepted January 31, 2012.
- Copyright © 2012 by AAN Enterprises, Inc.
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Disputes & Debates: Rapid online correspondence
You May Also be Interested in
- Research ArticleLong-term Dietary Flavonoid Intake and Subjective Cognitive Decline in US Men and WomenTian-Shin Yeh, Changzheng Yuan, Alberto Ascherio, et al.July 28, 2021
- April 25,2012Isoflavone-Rich Soy Protein and Cognition in Midlife and Late-Life Women: Randomized, Double-Blind, Placebo-Controlled Trial (P04.196)Victor Henderson, Jan St. John, Howard Hodis, et al.February 08, 2016
- ArticlePattern of polyphenol intake and the long-term risk of dementia in older personsSophie Lefèvre-Arbogast, David Gaudout, Julien Bensalem, et al.April 27, 2018
- ArticleRaloxifene for women with Alzheimer diseaseA randomized controlled pilot trialVictor W. Henderson, Tom Ala, Kristin L. Sainani, et al.November 04, 2015
- ArticleCognitive effects of estradiol after menopauseA randomized trial of the timing hypothesisVictor W. Henderson, Jan A. St. John, Howard N. Hodis, et al.July 15, 2016